RBV Capital is a venture capital and private equity firm investing in life science technology companies that is headquartered in Zug, Switzerland and was founded in 2014 by Alexey Konov and Robert Karl. Sectors RBV invest in include: life science, pharmaceuticals, biologics, digital healthcare products, and medical devices. Notable investments made by RBV Capital include: RetroSense Therapeutics, Bonti, Image Analysis Ltd., Immusoft, Botkin.AI, and AGCT.

A venture capital and private equity firmInvestingfirm investing in life science technology companies.